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Bone loss is still a major problem in orthopedics. The purpose of this experimental study is to evaluate the safety
and regenerative potential of a new scaffold based on a bio-ceramization process for bone regeneration in long
diaphyseal defects in a sheep model. The scaffold was obtained by transformation of wood pieces into porous
biomorphic silicon carbide (BioSiC). The process enabled the maintenance of the original wood microstructure,
thus exhibiting hierarchically organized porosity and high mechanical strength. To improve cell adhesion and
osseointegration, the external surface of the hollow cylinder was made more bioactive by electrodeposition of a
uniform layer of collagen fibers that were mineralized with biomimetic hydroxyapatite, whereas the internal
part was filled with a bio-hybrid HA/collagen composite. The final scaffold was then implanted in the meta-
tarsus of 15 crossbred (Merinos-Sarda) adult sheep, divided into 3 groups: scaffold alone, scaffold with platelet-
rich plasma (PRP) augmentation, and scaffold with bone marrow stromal cells (BMSCs) added during
implantation. Radiological analysis was performed at 4, 8, 12 weeks, and 4 months, when animals were sacri-
ficed for the final radiological, histological, and histomorphometric evaluation. In all tested treatments, these
analyses highlighted the presence of newly formed bone at the bone scaffolds’ interface. Although a lack of
substantial effect of PRP was demonstrated, the scaffold +BMSC augmentation showed the highest value of
bone-to-implant contact and new bone growth inside the scaffold. The findings of this study suggest the
potential of bio-ceramization processes applied to vegetable hierarchical structures for the production of wood-
derived bone scaffolds, and document a suitable augmentation procedure in enhancing bone regeneration,
particularly when combined with BMSCs.
Introduction
Abone defect can be caused by several pathologicalconditions (bone tumors, infections, major trauma with
bone loss.) or by surgical procedures,1 and the associated
loss of function considerably impairs the quality of life of the
affected patients.2 Unfortunately, extensive bone loss or de-
struction is still a major problem in orthopedics, due, in large
part, to the lack of predictability in obtaining functional bone
reconstruction.1,3–9
Bone tissue engineering offers a promising strategy for
healing severe bone injuries by utilizing the body’s natural
biological response to tissue damage in conjunction with
engineering principles.10 The limiting factor is represented
by the insufficient strength of currently available scaffolds,
although so far a good compromise in terms of mimicking
the micro- and macro-porosity of natural bone was
reached.11–13 Indeed, the remarkable biomechanical proper-
ties of bone depend on its hierarchically organized structure,
from the molecular to nano-, micro-, and macro-scales, which
make it able to constantly adapt to ever-changing mechani-
cal needs.14,15 In this regard, only scaffolds endowed with
a hierarchically organized structure can exhibit complex
biomechanical performances that are able to activate me-
chanotransduction processes, yielding regeneration of well-
organized bone.
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Natural woods manifest behavior similar to bones in terms
of elasticity, lightness, and strength. In this regard, some woods
can be transformed into porous devices acting as scaffolds and
exhibiting pore size and organization that are suitable to mimic
the biomechanical characteristics of human bone.16–18
The purpose of this experimental study is to evaluate the
safety and regenerative potential of a new scaffold based on
a bio-ceramization process16,17,19 for bone regeneration in
long diaphyseal defects in a sheep model. The scaffold was
obtained by the transformation of wood pieces into porous
biomorphic silicon carbide (BioSiC). The process enabled
the maintenance of the original wood microstructure, thus
exhibiting hierarchically organized porosity and high me-
chanical strength. Natural woods manifest behavior similar
to bones in terms of elasticity, lightness, and strength;
therefore, by translating its structure into bioactive, highly
porous scaffolds, a bone substitute prototype exhibiting both
the biochemical and biomechanical characteristics of human
bone has been developed. Its microstructure can mimic the
cortical part of bone; in this regard, to provide increased
biomimesis with bone and improved osteoconductivity, the
scaffold was conceived and designed as a bi-layer device. It
was made of an external, cortical-like, shell represented by
BioSiC, and a spongy-like core, made of a highly bioactive
hybrid composite obtained by a biologically inspired process
of self-assembling and mineralization of a collagen matrix
with nano-nuclei of Mg- and CO3- co-substituted hydroxy-
apatite.20–24 In addition, since no single approach can suc-
cessfully meet all the demands of bone regeneration alone
and the concept of providing a combination of the key ele-
ments for tissue healing (an osteoconductive matrix, osteo-
genic cells, and growth factors) is commonly proposed in the
scientific community, it was also tested whether loading
autologous cells (bone marrow stromal cells [BMSCs]) or
growth factors (derived from platelet rich plasma [PRP]) on
the scaffold might enhance the repair process. An emerging
option to provide viable osteogenic cells directly in the open
theatre, with no need of cell expansion, and therefore lower
costs and regulatory limitations, is the use of autologous
bone marrow concentrate.25 This overcomes long-lasting and
expensive in vitro culture expansion, avoiding the possibility
of transformation of the cell phenotype and overcoming the
strict rules on cell manipulation that, requiring a Good
Manufacturing Practice facility in processing and isolating
MSCs for clinical applications, greatly limit their use. Despite
the fact that quality parameters cannot be reliably predicted,
some publications indicate that, compared with the trans-
plantation of a defined type of cell, applying mixed popu-
lations of mesenchymal and hematopoietic progenitor cells
at different stages of differentiation is more effective for os-
teogenic regeneration.26,27 Thus, we applied this cell popu-
lation to the scaffold to increase the regeneration process.
Another possibility for favoring bone regeneration is the
application of growth factors, which are expressed during
different phases of tissue healing and are, therefore, a key
element to promote tissue regeneration.28 In fact, growth
factors carried out on orthopedic devices have been reported
to enhance osteoblastic activity and thus bone regenera-
tion.29,30 Platelets participate predominantly in the early re-
generation phases and, by degranulating, they produce a
great number of growth factors that initiate and maintain the
healing process.31,32 PRP is an inexpensive way to obtain
many platelets and therefore many growth factors, and it has
already been largely applied as a carrier of growth factors in
different fields of medicine.33–35 Nevertheless, the existing data
in preclinical and clinical studies are controversial; results can
be seen only at certain concentrations and even detrimental
effects have been reported.36–42 Therefore, we decided to test
the potential of this biological strategy for tissue-healing en-
hancement on this new scaffold in the big animal model, in
order to have clear indications on the most suitable augmen-
tation approach for a future clinical application.
Materials and Methods
Scaffold development
Cortical-like part. The cortical-like part of the scaffold was
manufactured as a hollow cylinder (external diameter: 15mm;
internal diameter: 9mm; height: 20mm) made of porous sili-
con carbide (BioSiC). The scaffold was obtained by biomorphic
transformation of Sipo wood (Entandophragma utile), following
a procedure reported elsewhere.43 In brief, blocks of Sipo
wood were pyrolized by heating at 800C under a flowing
argon atmosphere (0.5C/min heating rate) to obtain a wood-
derived carbon template (Fig. 1b) that was subsequently ma-
chined to a hollow cylinder using a lathe. The morphology of
Sipo wood is characterized by oriented porosity; hence, in
order to improve the cell conduction within the scaffold thus
favoring osteointegration and physical stabilization of the
bone-implant interface, the scaffold was developed by cutting
wood sources so as to keep pores exposed toward the bone
(Fig. 1a–e). Then, the pyrolyzed wood was melt-infiltrated
with silicon (Silgrainc HQ - 99.7% purity) by heating for more
than 1450C in a vacuum furnace. An Si/C weight ratio of 3.2
was used to ensure a complete conversion of C to SiC. The
obtained material consisted of a porous ceramic SiC scaffold
mimicking the original wood structure, with residual Si filling
some of the pores (Fig. 1c). Residual Si was removed by wet
chemical etching using an HF/HNO3 mixture at a molar ratio
of 1.66 in water under stirring, to obtain a hollow, porous SiC
cylinder with elongated porosity (Fig. 1d).
The resulting bioSiC scaffolds had an average apparent
density of (1.77 – 0.08) g$cm- 3, with a porosity estimated as
45% volume by geometrical arguments. An image analysis of
transverse sections showed a bimodal pore distribution of
approximately 40% large diameter pores (150 – 20 mm) and
60% small diameter pores (7 – 3 mm). Figure 2 describes the
mechanical strength of the porous Sipo-derived scaffold
versus porosity, as well as a morphological comparison be-
tween the starting wood and the final SiC scaffold.
To improve cell adhesion and osseointegration, the external
surface of the hollow cylinder was made more bioactive by
electrodeposition of a uniform layer of collagen fibers that were
mineralized with biomimetic hydroxyapatite.44 The electrode-
position process was carried out in a two-electrode cell, where a
work electrode (cathode)was constituted by the BioSiC shell and
the counter-electrode (anode) was constituted by a platinum
filament. The electrodes were immersed into a cell containing a
mixture of aqueous solutions and a collagen suspension, pre-
pared as follows. SolutionA: dissolution of Ca(NO3)2 in distilled
water for an approximate concentration of Ca2+ of 42mM. So-
lution B: dissolution of NH4H2PO4 in distilled water for an ap-
proximate concentration of PO4
3- of 25mM. The suspension of
Type I collagen was prepared starting by Achille’s tendon of
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horses following a proprietary method by Opocrin S.p.A.,20
which enables to obtain a purified and telopeptide-free product
in the form of a 1% (w/v) suspension.
The electro-deposition was carried out at 25C with an
applied constant galvanostatic current of 34 mA. The process
allowed the fibration of collagen fibers and mineralization
with nanonuclei of hydroxyapatite, during electrodeposition,
with the formation of a uniform layer of mineralized collagen
on the BioSiC scaffold; the layer thickness was related to the
deposition time; in this regard, the deposition time was ca-
librated to achieve a coating of 50 mm in thickness.44 After
each deposition, the coated BioSiC was washed in distilled
water and dried in air.
Spongy-like part. Bio-hybrid HA/collagen composites
were synthesized by neutralization of a suspension containing
Ca(OH)2 and MgCl2 with acidic solution containing phos-
phoric acid and Type I collagen (OPOCRIN SpA). The vari-
ation of pH from 3.5 to 9–10 during the process enabled the
assembling of collagen molecules into fibers, and simulta-
neous heterogeneous nucleation of biomimetic HA nano-
particles was achieved by pH variation, in the presence of
Ca2+ , Mg2+ , CO3
2- , and PO4
3- ions.20,21 The concentration of
Ca2+ and PO4
3- was adjusted to achieve the heterogeneous
nucleation of the mineral phase in amounts mimicking the
bone tissue (i.e., 70wt%). The concentration of Mg2+ and
CO3
2- was adjusted to achieve ion content (in the site of
calcium and phosphate, respectively) in biological-like
amounts. The obtained gel was subjected to freeze drying and
cut in the desired shape and size.
Assembling of the two components. The hollow BioSiC
cylinder was filled with the bio-hybrid composite (Fig. 1). The
fair elasticity of the spongy-like hybrid composite enabled its
insertion in the hollow cylinder by press-fit, thus obtaining a
stable bi-layered scaffold. The final scaffold, hereinafter re-
ferred to as BioSiC(HaCol), was sterilized by g-ray irradiation
at 25kGy (GammaRad Italia SpA, Bologna, Italy).
Preparation of PRP
PRP was prepared as follows according to the method
described in 2004 by Weibrich et al.37: Before scaffold
FIG. 1. BioSiC(HaCol) scaffold
design. (a–e) Puts in evidence the
complex microstructure of the ex-
ternal shell made of Sipo-derived
SiC, particularly evidencing the
oriented porosity (b, d), and the
alteration of the surface due to the
coating (c, e). (f, g) Highlights the
structure of the spongy part of the
scaffold. (h) Shows the final as-
sembled scaffold: The load-bearing
part is represented by the external
shell, whereas the internal part is
intended to promote osteo-
conductivity and bone regeneration
due to the high biomimesis with
bone (see Sprio et al.21).
FIG. 2. (a) Mechanical strength of porous, Sipo-derived
BioSiC in compression in the axial direction and in four-point
bending in the axial and the transversal directions of the
original wood pores. Compression data are from,43 bending
data are previously unpublished. (b) SEM micrograph of the
carbon scaffold obtained from pyrolysis of Sipo Wood. (c)
BioSiC/Si material obtained by infiltrating the previous
scaffold with molten Si, and (d) BioSiC, a porous SiC ceramic
mimicking the original wood precursor’s microstructure.
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implantation (within about 2 h), *20mL of peripheral ve-
nous blood was collected into siliconized tubes containing
3.8% sodium citrate at a blood/citrate ratio of 9/1. PRP was
obtained by two sequential centrifugations: at 200 g for 5min
and at 1000 g for 15min. The number of platelets (PLTs) was
determined on whole blood and on PRP under a microscope
with a hemocytometer chamber after 1/100 dilution with 1%
ammonium oxalate. The % yield was calculated in the fol-
lowing way: number of PLTs in PRP/number of PLTs in the
whole blood · 100. Platelet number (mean – SD) on whole
blood was 348– 145· 103/mm3 (range 250–560 · 103/mm3);
on PRP, it was 2018– 851 · 103/mm3 (range: 1200–
3040 · 103/mm3), with a mean % yield of 582% – 119% (range
462%–745%). After platelet counting, the PRP was re-
suspended in platelet-poor plasma, so as to obtain a platelet
concentrate equal to 1· 106/mL plasma. For platelet activa-
tion, a sterile 10% solution of CaCl2 (Sigma-Aldrich S.r.l.,
Milan, Italy) in the proportion 50mL/mL was added to the
PRP immediately before use and 2mL of PRP were soaked
into the scaffold.
Preparation of BMSCs
Before scaffold implantation, a 16-gauge bone-marrow
needle was inserted into the posterior iliac crest. A 10-mL
syringe was attached to the needle and a total bone marrow
volume of 6–7mL was collected in sterile vials containing
0.5mL of 1:1000 heparin to prevent clotting, and was im-
mediately processed by isopyknic centrifugation to concen-
trate the relatively few stem cells, thus improving bone
marrow osteogenic efficiency. Briefly, an equal volume of
phosphate-buffered saline (PBS) was added to the bone
marrow, the mixture was then layered over undiluted Ficoll
Paque (Sigma-Aldrich S.r.l.), which had a density of 1.083 g/
mL and was centrifuged for 20min at 400 g. The band of
light-density cells was separated, washed, counted
(4 – 2 · 106 cells/mL), and resuspended in 200 mL of PBS for
immediate implant. The whole procedure was performed
under sterile conditions.
Study design
All in vivo experiments were performed in accordance with
the European and Italian Law on animal experimentation and
the principles stated in the ‘‘NIH Guide for the Care and Use
of Laboratory Animals.’’ The research protocol on animals
was approved by the ethics committee of the Rizzoli Ortho-
paedic Institute and then by the Italian Ministry of Health.
Fifteen crossbred (Merinos-Sarda) adult sheep, aged
3.0 – 0.5 years, 65– 5 kg b.w. (Pancaldi Raffele, Budrio, Bo-
logna, Italy), after a quarantine period, were submitted to
surgery. General anesthesia was induced with 6mg/kg i.v.
sodium thiopentone (2.5% solution) (Thiopental Inresa,
Freiburg, Germany) and maintained with 60%/40% O2/air
7 L/min and 2% isoflurane (Aerrane, Baxter SpA, Roma). All
surgeries were carried out in aseptic conditions.
Each animal was placed on its left side, and the right hind-
limb was shaved and disinfected. A medial approach to the
metatarsus shaft was performed directly above the bone, and
the medial aspect of the metatarsus was exposed. A 3.5-mm
broad titanium dynamic compression plate with eight holes
was contoured to the shaft; a high-speed perforator was used
to drill the holes. The plate was fixed to the bone using
3.5mm screws and distributing three screw holes distally
and three proximally to the planned defect. Tapping and
screw insertion was done manually. Thereafter, the defect
was marked on the bone ensuring a standardized 2 cm defect
between the fourth and fifth screw hole. The screws and
plate were removed. The defect was cut with an oscillating
saw under constant irrigation and preservation of soft tissues
using two retractors inserted on both sides of the defect. The
2-cm segment was carefully removed; once the implant was
applied, the screws were placed again in the proper site and
the soft tissues were closed.
The created gap was treated according to the following
three groups: In group 1, the scaffold was implanted alone
(five sheep); in group 2, the scaffold was implanted with PRP
augmentation (five sheep); and in group 3, BMSCs were ad-
ded during implantation (five sheep). Then, a full cast was put
on the treated leg. The sole of the claws was closed for 8
weeks, then left open to ensure weight bearing on the fracture
site, but to prevent torsional or shear forces through the im-
mobilization of the metatarsus shaft through the cast. At 12
weeks after surgery, the sheep were then let out to graze. The
cast was changed twice at 4 and 8 weeks or on need (Fig. 3).
Radiographs of the operated limb were taken postopera-
tively at 4, 8, and 12 weeks (under sedation with ketamine
and xylazine as described earlier) by means of a portable
X-ray machine (Nessey HF30-Raffaello-ACEM SpA, Bolog-
na, Italy).
Four months after surgery, the animals were pharmaco-
logically euthanized with the i.v. administration of 10mL m-
butamide, mebenzonium iodine, and tetracaine chloride
(Tanax; Hoechst, Frankfurt am Main, Germany), under
general anesthesia. For each animal, the right metatarsus was
excised and stripped of soft tissue; the presence of haema-
tomas, oedema, and inflammatory tissue reactions were
macroscopically evaluated. Then, bone segments were
antero-posterior and medio-lateral radiographed, fixed in 4%
buffered paraformaldehyde for 48 h, and processed for his-
tological and histomorphometric investigations.
Radiological analysis
A score system was used to evaluate radiographs;45 it
ranges from 0 to 2 given for the proximal and distal os-
teotomy line in two different categories: osteotomy healing
and periosteal callus presence. In the first category, 0 was
assigned when there was discontinuity in the osteotomy line,
1 for continuity but the line was still visible, and 2 when the
line was hardly recognizable. With regard to periosteal cal-
lus, 0 indicated no evidence of periosteal callus, 1 indicated
FIG. 3. Scaffold implantation procedure. Color images
available online at www.liebertpub.com/tea
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moderate presence, and 2 indicated marked/exuberant
presence.
Histological and histomorphometric analyses
Undecalcified bone specimens were fixed in 4% parafor-
maldehyde, dehydrated in graded series alcohols, and em-
bedded in poly-methyl methacrylate (Merck, Schuchardt,
Hohenbrunn, Germany). Metatarsi were sectioned longitu-
dinally and along a plane parallel to the long axis of the
plate, respectively, using the same cutting-grinding system
(EXAKT 400CS Micro Grinding System; EXAKT Apparatus
GmbH, Norderstedt, Germany). Two sections for each sam-
ple were then automatically thinned to 80– 10mm with a
diamond grinding foil (ATM GmbH, Emil-Reinert-Str. 2, D-
57636 Mammelzen), and subsequently polished (Struers
Dap-7, Struers Tech, Denmark) to a thickness of 40 – 10 mm.
Sections were stained with Toluidine Blue, Acid Fuchsin,
Fast Green.
Bone histomorphometric measurements were performed
semi-automatically inside and outside the scaffold in four
equidistant regions of interest (2584· 1936 pixels) (Fig. 4) by
using an optic microscope (BX51; Olympus Optical Co.,
Europa GmbH, Germany) that was connected to an image
analyzer system (Qwin; Leica Imaging Systems Ltd., Cam-
bridge, United Kingdom) at 1.25 ·magnification. To evaluate
the scaffold osseointegration and healing bone process, the
following static measurements were done:46
– Bone-to-implant contact (%): the amount of bone contact
at the interface, defined as the percentage of implant
perimeter showing a direct bone-to-implant contact
without any intervening soft-tissue layers.
– New bone growth inside (%): the amount of new bone
growth next to scaffold in an area located inside scaffold
and expressed as a percentage.
– New bone growth outside (%): the amount of new bone
growth next to scaffold in an area located outside scaf-
fold and expressed as a percentage.
Statistical analysis
Statistical analysis was performed using the SPSS v.12.1
software (SPSS, Inc., Chicago, IL). Data are reported as
mean – SD at a significance level of p< 0.05. ANOVA fol-
lowed by the Dunnett t-test was used to analyze data.
Results
Two sheep died postoperatively (one in BioSiC(HaCol) +
PRP group and the other in BioSiC(HaCol) +BMSC group)
for postoperative problems not related to implants. At eu-
thanasia, macroscopic evaluation showed the implants to be
in the proper position. There were no signs of inflammation
or adverse tissue reaction in bone, peri-implant soft tissue,
and/or integument associated with implants.
Radiological analysis
Osteotomy lines healed with time in BioSiC(HaCol) group,
but were almost detectable at 16 weeks after surgery. The use
of PRP or BMSCs did not further improve the osteotomy
healing, where osteotomy lines were constantly and perfectly
visible during time (Figs. 5 and 6a). The area of the periosteal
callus increased over time in all groups (Figs. 5 and 6b). In
the BioSiC(HaCol) group ( p < 0.005), significant increases in
the periosteal callus score were observed at 12 (2.0 – 0.2) and
16 (2.0 – 0.2) weeks after surgery in comparison with those at
4 (0.0) weeks. Apart from this, in the BioSiC(HaCol) +PRP
and BioSiC(HaCol) +BMSC groups, significant increases in
the periosteal callus score ( p< 0.005 and p< 0.05, respective-
ly) were observed at 12 [BioSiC(HaCol) +PRP: 1.5 – 1.0; Bio-
SiC(HaCol) +BMSC: 3.5 – 0.5] and 16 [BioSiC(HaCol) +PRP:
2.5 – 1.0; BioSiC(HaCol) +BMSC: 3.5 – 0.5] weeks after sur-
gery in comparison with those at 4 weeks [BioSiC(HaCol) +
PRP: 0.0; BioSiC(HaCol) +BMSC: 1.0 – 0.4]. Significantly
higher values in periosteal callus score were found in Bio-
SiC(HaCol) +BMSC group in comparison to BioSiC(HaCol)
FIG. 4. Images of four equidistant region of interest
(2584· 1936 pixels—dashed rectangles) for the evaluation of
histomorphometric measurements, performed inside and
outside the scaffold: bone-to-implant contact (%), new bone
growth inside (%), and new bone growth outside (%). To-
luidine Blue, Acid Fuchsin, Fast Green staining. Scanner
Epson 2480 Photo, Resolution 1200 dpi. Color images avail-
able online at www.liebertpub.com/tea
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( p< 0.05) at 4 [BioSiC(HaCol) +BMSC: 1.0 – 0.4; BioSiC(Ha-
Col): 0.0] and 8 [BioSiC(HaCol) +BMSC: 2.8 – 0.8; Bio-
SiC(HaCol): 0.8 – 0.4] weeks from surgery.
Histological and histomorphometric analyses
Histological evaluation showed neither inflammatory
processes nor fibrous encapsulation at the bone-scaffold in-
terface for all treatments.
Group 1: BioSiC(HaCol). BioSiC(HaCol) scaffolds pre-
sented dense and irregular connective tissue at the edges of
the device characterized by a number of collagen fibers that
clump together in bundles, sometimes accompanied by net-
works of elastic tissue. Newly formed bone tissue was
present within the scaffold with an hourglass shape. The new
bone was comparatively mature containing many bone la-
cunae. However, several areas of low bone-to-implant con-
tact were observed on BioSiC(HaCol) surfaces (Fig. 7a).
Group 2: BioSiC(HaCol) +PRP. BioSiC(HaCol) scaf-
folds +PRP showed irregular dense connective tissue at the
edge of the scaffold and between scaffold and cortical bone.
The cortical areas in contact with the scaffold were spongy
and eroded, with connective tissue interspersed with newly
formed bone and small particles of the scaffold. The use of
PRP improved the bone growth tissue inside the scaffold,
and newly formed bone tissue was present within the scaf-
fold. Nevertheless, areas of low bone-to-implant contact
were also observed on BioSiC(HaCol) scaffolds +PRP sur-
faces (Fig. 7b).
Group 3: BioSiC(HaCol) +BMSCs. BioSiC(HaCol) scaf-
folds +BMSCs presented dense connective tissue at the edge
of the scaffold, probably due to the persistence of bone cal-
lus, and newly formed bone tissue was present within the
scaffold. Conversely to BioSiC(HaCol) and BioSiC(HaCol) +
PRP (Fig. 7), BioSiC(HaCol) scaffolds +BMSCs exhibited a
well-defined continuous layer of new bone. In addition, in
comparison to BioSiC(HaCol) and BioSiC(HaCol) +PRP,
bone osseointegration and remodeling processes were more
evident with higher amounts of bone in contact with im-
plants. In addition, the BioSiC(HaCol) scaffolds +BMSCs
were partly covered with mineralized bone containing many
bone lacunae and several osteoblasts (Fig. 7c).
Histomorphometric analyses provided a better compre-
hension of osseointegration and new bone formation pro-
cesses (Table 1). In particular, Scheffe´ post hoc multiple
comparison test highlighted differences in terms of bone-to-
implant contact and new bone growth inside scaffold. Bone-
FIG. 5. Radiological images of periosteal callus presence and osteotomy healing at the proximal (upper) and distal (bottom)
osteotomy line at 0 (a, f, k), 4 (b, g, l), 8 (c, h, m) 12 (d, i, n), and 16 (e, j, o) weeks after surgery: BioSiC(HaCol) (a–e);
BioSiC(HaCol) +PRP (f–j); and BioSiC(HaCol) +BMSCs (k–o). PRP, platelet-rich plasma; BMSC, bone marrow stromal cell.
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to-implant contact revealed significantly higher values in
BioSiC(HaCol) +BMSCs when compared with BioSiC(Ha-
Col) alone and BioSiC(HaCol) +PRP ( p< 0.005). With regard
to the new bone growth inside scaffold, BioSiC(HaCol) +
BMSCs and BioSiC(HaCol) +PRP highlighted significantly
higher value in comparison to BioSiC(HaCol) alone ( p< 0.005
and p < 0.05 respectively).
Discussion
This study showed the safety, feasibility, and potential of
this scaffold in vivo in a sheep model, as shown by radiolog-
ical, histological, and histomorphometrical evaluations. In all
tested treatments these analyses highlighted the presence of
newly formed bone at the bone scaffolds interface. In partic-
ular, BioSiC(HaCol)+BMSC showed the highest value of
bone-to-implant contact and new bone growth inside the
scaffold. Hence, the obtained results have shown the potential
of this scaffold in particular when combined with BMSCs.
During the last decades, a variety of scaffolds have been
developed, and launched in the market, in order to face the
increasing need for bone substitutes.47–53 To date, acceptable
clinical results have been obtained but no suitable solutions
have been found as yet for regenerating long and load-
bearing bone segments: Indeed, the mechanical strength of a
highly porous but ‘‘disorganized’’ scaffold is often insuffi-
cient in order to manage the in vivo stresses and physiolog-
ical loadings. So far, the development of three-dimensional
synthetic systems with hierarchical architecture have been
limited by the currently available processing technology.54,55
In recent years, material scientists have focused their at-
tention on natural structures (e.g., shells, nacre, and wood,
plants) and to their astonishing mechanical properties, gen-
erated by the complex and hierarchical organization of their
FIG. 6. Radiological score
evaluation in terms of os-
teotomy healing (a) and peri-
osteal callus presence (b) until
16 weeks after surgery. Dun-
nett t-test: periosteal callus
presence: a, BioSiC(HaCol) +
BMSCs group versus Bio-
SiC(HaCol) at 4 and 8 weeks
( p< 0.05); b, 12 and 16 weeks
versus 4 weeks in BioSiC(Ha-
Col) and BioSiC(HaCol) +PRP
group ( p< 0.005); c, 12 and 16
weeks versus 4 weeks in Bio-
SiC(HaCol) +BMSCs group
( p< 0.05).
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FIG. 7. Histological images
showing bone osseointegra-
tion and newly formed bone
tissue: BioSiC(HaCol) (a, d,
g); BioSiC(HaCol) +PRP (b, e,
h); and BioSiC(HaCol) +
BMSCs (c, f, i). Toluidine
Blue, Acid Fuchsin, and Fast
Green staining. Magnifica-
tion: (a–c), 1· ; (d–f), 4 · ;
(g–i), 20· . (a–c) Histological
(sagittal) and microtomo-
graphic (longitudinal and
coronal) images by Scanner
Epson 2480 and Skyscan 1172
system (100 kV, 100 mA,
0.5mm aluminum filter, soft-
ware NRecon v.1.6.2.0), re-
spectively. (d–f) Histological
images of bone growth inside
the bioactive HaCol core of
the scaffold; (g–i) cortical
bone contact to the biomor-
phic shell made of BioSIC.
NB, new bone; OcB, old cor-
tical bone (calcified bone
stains a bright green); Sc,
cortical-like scaffold; Ss,
spongy-like part scaffold
(blue or light brownish).
Color images available online
at www.liebertpub.com/tea
Table 1. Histomorphometric Results for the Three Groups of Treated Sheep (Mean– SD)
Scaffold parameter BioSiC(HaCol) (n = 5) BioSiC(HaCol) +PRP (n = 4) BioSiC(HaCol) +BMSC (n = 4)
Bone-to-implant contact (%) 15.0 – 2.6 14.9 – 2.8 26.8 – 3.7a
New bone growth outside scaffold (%) 11.6 – 4.2 15.1 – 5.0 14.4 – 4.6
New bone growth inside scaffold (%) 26.8 – 3.7 38.5 – 5.8b 41.1 – 4.6c
Scheffe´ post hoc multiple comparison test.
aBioSiC(HaCol)+BMSC versus BioSiC(HaCol) and ( p < 0.005).
bBioSiC(HaCol) +PRP versus BioSiC(HaCol) ( p < 0.05).
cBioSiC(HaCol)+BMSC versus BioSiC(HaCol) ( p< 0.005).
PRP, platelet rich plasma; BMSC, bone marrow stromal cell.
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structure.56 Woods have a porous structure similar to that of
bone;57 consequently, they manifest similar properties, that
is, high elasticity, lightness, and strength. The conversion of
woods into inorganic devices with complex morphology (i.e.,
biomorphic transformation) has been attempted for the past
two decades.58–60 Processes to convert natural woods into
biomedical devices were carried out and optimized, thus
leading to the development of BioSiC16,17,61–68 a biocompat-
ible ceramic which can be developed starting from different
raw materials, that is, ligneous sources (e.g., red oak, sipo),
so as to exhibit different complex microstructure and po-
rosity. In particular, BioSiC obtained by transformation of
hard woods is characterized by high strength that is able to
sustain strong mechanical loads and porous morphology
which is able to promote cell adhesion and attachment (see
also Fig. 1a–e).43
A similar approach to reproduce the spongy part of bone
has been carried out for the past decade, by reproducing in a
laboratory the biomineralization processes that in vivo lead to
the formation of new bone tissue.21,69 In this regard, hybrid
hydroxyapatite/collagen composites were developed, where
the mineral phase was heterogeneously nucleated on the self-
assembling collagen fibers in a specific manner, due to
several control mechanisms (i.e., chemical, physical, mor-
phological, and structural) acting at different dimensional
ranges, from the molecular up to the macroscopic scale.43
This led to the development of commercial products (i.e.,
RegenOss, MaioRegen) for the regeneration of bone and
osteochondral tissues.
In the present work, in order to achieve high mimesis of
the chemico-physical, morphological, and mechanical fea-
tures of natural bones, hence to promote the formation of
new tissue, the two products were combined to develop a bi-
layered, bi-phasic bone-mimicking scaffold.19
The study also documented another important aspect for
further increasing the tissue regeneration potential: the ben-
eficial effects of a cell–scaffold combination. The concept of
providing a combination of the key elements for tissue
healing (an osteoconductive matrix, osteogenic cells, and
growth factors) is well accepted in the scientific community:
In fact, no single approach can successfully meet all the de-
mands of bone regeneration alone.70 The creation of viable
bone tissue equivalent is facilitated by providing metaboli-
cally active cells that are able to contribute through their
continuous matrix synthesis. While there is still no unani-
mous agreement on the most suitable cell type, preclinical
in vivo studies have proved the positive effects of cells on
bone regeneration, and promising findings have also been
reported from human applications.3,71,72
The results of this study gave us clear indications with
regard to the potential of combined implantation procedures.
In fact, both the use of MSCs through the application of a
bone marrow concentrate and platelet-derived growth fac-
tors were tested, and we clearly demonstrate the lack of
substantial effect of PRP on one hand, and the improved
results with the combined use of BMSCs and the new scaf-
fold on the other hand.
The findings of this study suggest the potential of bio-
ceramization processes that are applied to vegetable hierar-
chical structures for the production of new wood-derived
bone scaffolds with good biological and mechanical prop-
erties, and document a suitable augmentation procedure in
enhancing bone regeneration, particularly when combined
with BMSCs. After this promising preliminary experience,
future studies are needed to evaluate whether different
scaffold prototypes, in terms of mechanical and biological
properties, could further improve this bioengineered ap-
proach, thus developing the optimal cell-based scaffold
strategy to be applied in a pilot study for enhancing bone
regeneration process in humans.
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